ISTENT TRABECULAR MICRO-BYPASS
Report
- Report Number
- 2032546-2019-00053
- Event Type
- Injury
- Date Received
- April 24, 2019
- Report Date
- April 24, 2019
- Manufacturer
- GLAUKOS CORPORATION
- Product Code
- OGO
- PMA / PMN Number
- P080030
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SD, US
- Reporter Occupation
- PHYSICIAN
Narratives
AGE OR DATE OF BIRTH: (MEAN AGE USED), SEX: (MODE USED). THE DEVICES WERE NOT AVAILABLE FOR RETURNED; THEREFORE, PRODUCT TESTING ON THESE ACTUAL DEVICES COULD NOT BE PERFORMED. DEVICE IDENTIFIERS WERE NOT PROVIDED; THEREFORE, THE DEVICE HISTORY RECORDS FOR THIS DEVICE LOT NUMBER COULD NOT BE REVIEWED. ELEVATED IOP IS IDENTIFIED IN THE LABELING AS A KNOWN INHERENT RISK OF TRABECULAR MICRO-BYPASS STENT PROCEDURE. THE IFU ADEQUATELY PROVIDES INSTRUCTIONS FOR STENT IMPLANTATION, PRECAUTIONS, AND WARNINGS FOR THE PROPER USE AND HANDLING OF THE DEVICE. MFR# REFERENCE: (B)(4). THIS STUDY WAS A CONTINUATION AND EXPANSION OF A PREVIOUS STUDY, REFERENCE MFR# (B)(4).
THROUGH A REVIEW OF THE ARTICLE "TRABECULAR MICRO BYPASS STENT IMPLANTATION IN PSEUDOPHAKIC EYES WITH OPEN-ANGLE GLAUCOMA: LONG-TERM RESULTS¿, THE FOLLOWING WAS REPORTED. NO CASES OF HYPOTONY OCCURRED POSTOPERATIVELY. THERE WERE NO INTRAOPERATIVE OR POSTOPERATIVE COMPLICATIONS OBSERVED RELATED TO THE STENT. FOR PRESSURE SPIKES ABOVE BASELINE, ONLY 3 (5.7%) OF THE 51 EYES EXPERIENCED AN IOP SPIKE OF 15 MM HG OR HIGHER AND 8 EYES (15.3%) HAD IOP SPIKES OF 10 MM HG OR HIGHER, ALL OCCURRING WITHIN 1 MONTH AFTER SURGERY. THIS WAS RETROSPECTIVE ANALYSIS OF DATA COLLECTED FROM 51 EYES OF 40 PATIENTS. PATIENTS WITH MILD TO SEVERE OPEN ANGLE GLAUCOMA WERE IMPLANTED WITH 1 TRABECULAR MICRO BYPASS STENT. PURPOSE: TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF A TRABECULAR MICRO BYPASS STENT AS A SOLE PROCEDURE IN PSEUDOPHAKIC EYES WITH OPEN-ANGLE GLAUCOMA. CONCLUSION: THE INSERTION OF A SINGLE TRABECULAR MICRO BYPASS STENT EFFECTIVELY PROVIDED A SUSTAINED REDUCTION IN IOP PSEUDOPHAKIC PATIENTS WITH MILD TO SEVERE OAG. THE IOP REDUCTION WAS MORE ROBUST IN EYES THAT HAD A HIGHER BASELINE IOP. ADDITIONAL INFORMATION HAS BEEN REQUESTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 338807 | ISTENT TRABECULAR MICRO-BYPASS | INTRAOCULAR PRESSURE LOWERING IMPLANT | OGO | GLAUKOS CORPORATION |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 83 YR | Other |